Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$11.85 - $15.47 $592,500 - $773,500
50,000 New
50,000 $734,000
Q1 2023

May 15, 2023

SELL
$8.79 - $14.58 $2,636 - $4,374
-300 Reduced 0.11%
276,000 $2.59 Million
Q4 2022

Feb 14, 2023

BUY
$11.49 - $13.65 $2.36 Million - $2.8 Million
205,400 Added 289.7%
276,300 $3.38 Million
Q3 2022

Nov 14, 2022

BUY
$12.41 - $32.42 $366,095 - $956,390
29,500 Added 71.26%
70,900 $880,000
Q2 2022

Aug 15, 2022

BUY
$19.63 - $26.62 $92,261 - $125,114
4,700 Added 12.81%
41,400 $813,000
Q1 2022

May 16, 2022

BUY
$24.65 - $29.0 $406,725 - $478,500
16,500 Added 81.68%
36,700 $958,000
Q3 2021

Nov 15, 2021

BUY
$29.2 - $36.72 $589,840 - $741,744
20,200 New
20,200 $644,000

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $5.42B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.